NicolasPalaskasMD
Cardiology • Houston, TXAdult Congenital Heart Disease
Medical Resident, Medicine, Baylor College of Medicine
Dr. Palaskas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
Baylor College of MedicineFellowship, Cardiovascular Disease, 2014 - 2017- Baylor College of MedicineResidency, Internal Medicine, 2011 - 2014
The University of Texas Health Science Center at San AntonioClass of 2011
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2027
TN State Medical License 2023 - 2026
TX State Medical License 2014 - 2026
WA State Medical License 2023 - 2026
GA State Medical License 2023 - 2025
LA State Medical License 2023 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- Join now to see all
Publications & Presentations
PubMed
- 9 citationsCoronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registry.Joseph Nowatzke, Paul Guedeney, Nicholas Palaskas, Lorenz Lehmann, Stephane Ederhy
European Journal of Cancer. 2022-12-01 - 231 citationsImmune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment.Nicolas Palaskas, Juan Lopez-Mattei, Jean-Bernard Durand, Cezar Iliescu, Anita Deswal
Journal of the American Heart Association. 2020-01-21 - 6 citationsPalliative care referral criteria and outcomes in cancer and heart failure: a systematic review of literatureAnecita P. Fadol, Ashley Patel, Valerie Shelton, Kate Krause, Eduardo Bruera
Cardio-Oncology. 2021-09-23
Press Mentions
MD Anderson Research Highlights: SITC 2024 Special EditionNovember 9th, 2024- Immune Checkpoint Inhibitors Linked to Range of Adverse Heart EffectsJuly 12th, 2022
- Allogene Therapeutics to Present at the Virtual 39th Annual J.P. Morgan Healthcare ConferenceNovember 12th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
